CoChat

Challenges in Cardiac and Pulmonary Sarcoidosis

Open access
Trivieri, Maria Giovanna, Spagnolo, Paolo, Birnie, David, Liu, Peter, Drake, Wonder, Kovacic, Jason C., Baughman, Robert, Fayad, Zahi A., Judson, Marc A. · 2020 · Journal of the American College of Cardiology
Cited by 216

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Sarcoidosis is a complex disease with heterogeneous clinical presentations that can affect virtually any organ. While the lung is typically the most common organ involved, combined pulmonary and cardiac sarcoidosis (CS) account for most of the morbidity and mortality associated with this disease. Pulmonary sarcoidosis can be asymptomatic or result in impairment in quality of life, end-stage severe and/or life-threatening disease. The latter outcome is seen almost exclusively in those with fibrotic pulmonary sarcoidosis, which accounts for 10–20 percent of pulmonary sarcoidosis patients. CS is problematic to diagnose and may cause significant morbidity and death from heart failure (HF) or ventricular arrhythmias. The diagnosis of CS usually requires surrogate cardiac imaging biomarkers as endomyocardial biopsy (EMBx) has relatively low yield, even with directed electrophysiologic mapping. Treatment of CS is often multifactorial involving a combination of anti-granulomatous therapy and pharmacotherapy for cardiac arrhythmias and/or HF in addition to device placement and cardiac transplantation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2020.08.042

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 216

Metadata

Authors
Trivieri, M. G., Spagnolo, P., Birnie, D., Liu, P., Drake, W., Kovacic, J. C., Baughman, R., Fayad, Z. A., & Judson, M. A.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2020-10
Volume
76
Issue
16
Pages
1878-1901
ISSN
0735-1097 (ISSN-L)
OpenAlex
W3093290872
Cited by
216
References
5
FWCI
14.21
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.